What's new

Human medicines European public assessment report (EPAR): Repaglinide Teva, repaglinide, Date of authorisation: 28/06/2009, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Repaglinide Teva, repaglinide, Date of authorisation: 28/06/2009, Revision: 10, Status: Authorised

Feb 11, 2025 - 16:50
 0
Human medicines European public assessment report (EPAR): Repaglinide Teva, repaglinide, Date of authorisation: 28/06/2009, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Repaglinide Teva, repaglinide, Date of authorisation: 28/06/2009, Revision: 10, Status: Authorised
Read More

Tags:

Previous Article

SWTCH Energy selected to power 2500 EV chargers in 136 Greystar Properties acros...

Next Article

Can the solar industry police itself?

Related Posts

European shortages monitoring platform (ESMP) API - Req...

Mar 27, 2025  0

Opinion on medicine for use outside EU: Ivermectin/Albendazole, ivermectin,albendazole, Parasitic Diseases,Helminthiasis,Hookworm Infections,Ascaridida Infections,Trichuriasis,Strongyloidiasis, 30/01/2025 Positive opinion

Opinion on medicine for use outside EU: Ivermectin/Albe...

Mar 18, 2025  0

Drug-Eluting stent (DES) - Notified Body 2265 - 10/01/2...

Mar 13, 2025  0